Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer’s Disease Mice
Author:
Affiliation:
1. Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan
2. National Center Hospital, National Center of Neurology and Psychiatry, Kodaira-shi, Tokyo, Japan
Abstract
Publisher
IOS Press
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Reference60 articles.
1. Engaging patients using an interprofessional approach to shared decision making;Dawn;Can Oncol Nurs J,2015
2. Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer’s disease: A systematic review and meta-analysis;Papanastasiou;J Gen Intern Med,2021
3. Characteristic features of cognitive, affective and daily living functions of late-elderly dementia;Hishikawa;Geriatr Gerontol Int,2016
4. Alzheimer mechanisms and therapeutic strategies;Huang;Cell,2012
5. Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer’s Disease Combined with Cerebral Hypoperfusion;Journal of Alzheimer's Disease;2023-11-07
2. Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation;Expert Review of Cardiovascular Therapy;2023-11-02
3. Causal relationship between Alzheimer’s disease and cardiovascular disease: a bidirectional Mendelian randomization analysis;Aging;2023-09-02
4. Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease;Biomedicines;2023-05-07
5. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?;British Journal of Pharmacology;2023-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3